| 发明名称 |
Aryl ureas with raf kinase and angiogenisis inhibiting activity |
| 摘要 |
This invention relates to methods of using aryl ureas to treat diseases mediated by raf kinase and diseases mediated by the VEGF induced signal transduction pathway characterized by abnormal angiogenesis or hyperpermeability processes.
|
| 申请公布号 |
US2004023961(A1) |
申请公布日期 |
2004.02.05 |
| 申请号 |
US20030361844 |
申请日期 |
2003.02.11 |
| 申请人 |
BAYER CORPORATION |
发明人 |
DUMAS JACQUES;SCOTT WILLIAM J.;ELTING JAMES;HATOUM-MAKDAD HOLIA |
| 分类号 |
A61K31/415;A61K31/4178;A61K31/4439;A61K31/5355;A61K31/5377;A61K31/541;A61K45/06;A61P17/06;A61P19/02;A61P27/02;A61P31/04;A61P31/06;A61P31/18;A61P35/00;(IPC1-7):A61K31/541;A61K31/537;A61K31/443 |
主分类号 |
A61K31/415 |
| 代理机构 |
|
代理人 |
|
| 主权项 |
|
| 地址 |
|
